{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T19:49:36Z","timestamp":1648928976451},"posted":{"date-parts":[[2016,3,30]]},"reference-count":0,"publisher":"Morressier","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.26226\/morressier.56d6be76d462b80296c9785c","type":"posted-content","created":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T15:21:58Z","timestamp":1582125718000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical and economical impact of a rapid susceptibility testing regarding blood cultures with Gram negative bacilli"],"prefix":"10.26226","author":[{"given":"Cidalia","family":"Pina-Vaz","sequence":"first","affiliation":[]}],"member":"22980","container-title":[],"original-title":[],"deposited":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T16:19:20Z","timestamp":1582129160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.morressier.com\/article\/56d6be76d462b80296c9785c"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,30]]},"references-count":0,"URL":"https:\/\/doi.org\/10.26226\/morressier.56d6be76d462b80296c9785c","relation":{},"subject":[],"published":{"date-parts":[[2016,3,30]]},"subtype":"other"}}